Introduction
Human herpesvirus-6 (HHV-6) is a betaherpesvirus classified along with human herpesvirus-7 in the Roseolavirus genus. Two distinct variants exist, designated HHV-6A and HHV-6B, that exhibit consistent differences in DNA sequence, reactivity to monoclonal antibodies, cell tropism and disease association (Pellett & Black, 1996) . The virus is ubiquitous with up to 95 % of adults in industrialized nations being seropositive. Infection commonly occurs by age 3 years and the virus is the causative agent of the childhood disease exanthem subitum (Yamanishi et al., 1988) . HHV-6 virus load and antibody titre is frequently elevated in renal allograft patients and reactivation associated with immunosuppression has been correlated with organ rejection. In bone marrow transplant recipients, HHV-6 is associated with rash, graft-versus-host disease, pneumonitis, febrile episodes and suppression of graft outgrowth. Furthermore, HHV-6A has been associated with rapid progression Author for correspondence : Gavin Wilkinson.
Fax j44 29 20745003. e-mail WilkinsonGW1!cf.ac.uk of human immunodeficiency virus (HIV)-related symptoms and both variants have also been linked in some studies with the pathogenesis of multiple sclerosis and chronic fatigue syndrome (Brenmer & Clark, 1999 ; Caserta et al., 2001) .
Concomitant HHV-6 and human cytomegalovirus (HCMV) infections occur frequently in immunosuppressed organ transplant patients (Irving et al., 1990 ; DesJardin et al., 1998) and, given that they infect overlapping cell types (Kondo et al., 1991 ; Taylor-Wiedeman et al., 1991) , the potential exists for the two viruses to interact directly in vivo. The HHV-6 genome (162-170 kb) is composed of a unique long segment bracketed by direct repeats. The unique long genomic elements of HHV-6 and HCMV are essentially collinear (Neipel et al., 1992) , with 67 % of HHV-6A (U1102) genes having counterparts in HCMV (Gompels et al., 1995) . In common with other herpesviruses, HHV-6 operates a cascade system of gene regulation conventionally divided into the immediate-early (IE), early and late phases. A positional homologue of the HCMV major IE gene (IE1) exists in HHV-6 (within the IE-A region). The HCMV major IE gene interacts with cellular factors (e.g. p107, E2F) and encodes a transcriptional trans-activator that acts synergistically with HCMV IE2 (Lukac et al., 1994) . HCMV IE1 is essential for efficient productive infection at low m.o.i. in vitro, but is dispensable at high-input m.o.i. (Mocarski et al., 1996) . HCMV IE1 induces the disruption of PML-bodies and causes both IE1 and PML to become associated with mitotic chromatin (Lafemina et al., 1989 ; Wilkinson et al., 1998) . PML-bodies (also known as ND10 or PODs) are punctate structures associated with the nuclear matrix that contain, or transiently associate with, an assortment of cellular proteins including SUMO-1, Sp100, Sp140, CBP, BLM, Daxx, pRB and p53 (Zhong et al., 2000) . PML is the defining marker for PMLbodies and is required for the recruitment of other proteins to the domain (Ishov, 1999) . PML modification by covalent linkage to SUMO-1 (a small ubiquitin-like molecule) is required for its migration to PML-bodies (Muller et al., 1998) . Both HCMV IE1 and IE2 are SUMO-modified and, in the case of IE2, this modification is necessary for its transactivating functions (Muller & Dejean, 1999 ; Hofmann et al., 2000) .
There is no obvious amino acid sequence homology between HCMV IE1 and its positional homologue in HHV-6. Four transcripts are produced from the HHV-6 IE-A region of which only one, designated HHV-6 IE1, is produced under IE conditions (Schiewe et al., 1994 ; Mirandola et al., 1998) . The HHV-6A IE1 transcript is produced from five exons ; translation is initiated in exon 3 and encodes an open reading frame (ORF) (2826 bp) predicted to encode a product of 104 kDa (IE1 *%"aa ). The designated HHV-6B IE1 ORF is slightly longer (3237 bp) and is predicted to encode a 120 kDa protein (IE1 "!()aa ) (Dominguez et al., 1999) . Interestingly, the IE-A region is the most variable part of the HHV-6 genome, with ORFs in this region showing only 63 % nucleotide identity between HHV-6A and HHV-6B variants as compared with an overall identity for all ORFs of 94 % (Isegawa et al., 1999) .
The herpesvirus IE genes exhibit extreme sequence variation and have diverse biological properties yet clearly play a pivotal role in both initiating and establishing the lytic phase of the replication cycle. We were intrigued by the elevated level of sequence variation in the IE1 region between the HHV-6 variants and its absolute divergence from its counterpart in HCMV. It is possible that while the sequence of this genetic element may have diverged during the evolution of the betaherpesviruses, many of its functions have been conserved. In this study we therefore sought to analyse the products of the HHV-6A and HHV-6B IE1 genes and, more specifically, to explore their potential interactions with components of PMLbodies.
Methods
Cells and viruses. HHV-6 variant A strain U1102 was kindly provided by U. Gompels (London School of Hygiene and Tropical Medicine, UK), and variant B strain Z29 was provided by D. Clarke (University College London, UK) with permission from P. E. Pellett (Centers for Disease Control and Prevention, Atlanta, Georgia). HHV-6 variants were propagated using Molt 3 cells (strain Z29), JJhan cells (strain U1102) or peripheral blood mononuclear cells (PBMC) (strain U1102) in RPMI (Sigma) supplemented with 10 % foetal calf serum and 5mM -glutamine (Life Technologies). To infect PBMCs, strain U1102-infected JJhan cells were incubated with 83 µg\ml mitomycin C (Sigma) at 37 mC for 20 min. Cells were washed twice in PBS and added to separated peripheral blood cells. Infected PBMC were stimulated with 0n1 units\ml interleukin-2 (Sigma) and 5 µg\ml lectin (Sigma).
DNA transfections were carried out using Polyfect (Qiagen) according to the manufacturer's standard protocol. U373 cells expressing 6iHis-tagged SUMO-1 (U373-SUMO) were generated by puromycin (Invitrogen) selection following transfection with pIRES-HisSUMO, kindly provided by D. Bailey (Marie Curie Research Institute, Oxted, UK). pZ29-GFP and pU1102-GFP (see below) were transfected into U373 cells and cell lines generated following G418 sulphate selection (2mg\ml ; Sigma).
Plasmid construction. The HHV-6 IE1 ORFs from strains U1102 (Gompels et al., 1995) and Z29 (Dominguez et al., 1999) were amplified by PCR from genomic DNA and cloned directly as C-terminal GFP fusion constructs in the transient mammalian expression vector pCT-GFP-TOPO (Invitrogen) to generate the plasmids pU1102-GFP and pZ29-GFP. HHV-6 template DNA was extracted from tissue culture preparations of the appropriate virus using a silica slurry method previously described (Boom et al., 1990) . For Z29 IE1 the 5h primer was Z29IE-CL (GATAAATTTGAGCATTTTCTTCG) and the 3h primer was A-IECL2 (GCGGTGTCTCAATTTGCATC). For U1102, the 5h primer A-IECL1 (GATAGATTTGAGCATTTTCTACG) and the 3h primer A-IECL2 were utilized. Primers were obtained from Oswel DNA services and HPLC-purified. The PCR conditions involved denaturation at 94 mC for 2 min ; 9 cycles of denaturation (94 mC for 30 s), annealing (50 mC for 30 s) and incubation (68 mC for 7 min) ; a further 19 cycles in which the incubation period increased by 20 s per cycle ; and finally incubation at 68 mC for 14 min. 100 pmol of each primer, 200 µM dNTPs (Amersham Biosciences), manufacturer's buffer containing 1n5 mM MgCl # and 1 unit Pwo polymerase (Hybaid) were used in a final reaction volume of 50µl. Thermocycling was undertaken in a PTC-100 thermocycler (GRI Ltd). All PCR-generated fragments for cloning were sequenced and constructs that matched the published sequence used for each variant.
A plasmid expressing a nuclear form of GFP was made by amplifying exons 2 and 3 of HCMV IE1 by PCR and inserting the fragment into the EGFP-N1 mammalian expression vector (Clontech) as an N-terminal GFP fusion.
Construction of a recombinant adenovirus. The complete HHV-6 IE1 ORF from strain U1102 was amplified using primers RS1 (GGCCGTCGACGCGGTGTCTCAATTTGCATC) and RS2 (GGCCA-CTAGTACATCTAGGTTTCATCTAGCTA) with the same cycling conditions as for the generation of pU1102-GFP and pZ29-GFP. The DNA sequence of the clone used in expression studies matched the published sequence (Gompels et al., 1995) . A replication-deficient adenovirus recombinant (RAdHHV-6) encoding HHV-6-IE1
*%"aa under the control of the HCMV major IE promoter was generated as described previously (Wilkinson et al., 1992) .
Immunohistochemistry. An anti-HHV-6 IE1-specific polyclonal antibody was generated by intraperitoneal murine immunization with the RAdHHV-6 recombinant as described previously (Tomasec et al., 2000) and diluted 1 in 100 for use in immunofluorescence and Western blots. Monoclonal antibodies to SUMO-1 (Zymed) and PML (Santa Cruz) and rabbit polyclonal antisera specific for PML (MBL) were diluted 1 in 100 for use in immunofluorescence. FITC-and Texas red-conjugated secondary antibodies were obtained from Sigma. Immunofluorescence CIBC and Western blotting conditions were performed as described previously (Sambrook & Russell, 2001b) . For co-immunofluorescence primary antibodies were mixed and applied together, as were secondary antibodies.
Immunoprecipitation. Extracts were made from U373 cell lines by lysing centrifuged intact cells in 500 µl RIPA buffer (0n5%, v\v, NP-40, 0n5%, w\v, sodium deoxycholate, 0n5%, w\v, SDS, 150 mM NaCl, 10 mM Tris pH 7n4, 5 mM EDTA, 2 mM PMSF, 4 mM N-ethylmaleimide). Lysates were cleared by centrifugation at 10 000 g (10 min). Rabbit polyclonal anti-GFP (2 µl ; Abcam, UK) was added to 500 µl lysate and incubated with mixing overnight at 4 mC. Protein A-agarose (20 µl ; Amersham Biosciences) was added for a further 3 h at 4 mC. Precipitated material was recovered by centrifugation (10 000 g for 10 min) and washed four times in RIPA buffer. The sample was boiled for 5 min in 1i SDS-PAGE running buffer containing 100 mM DTT and analysed in Western blot experiments (as above) following electrophoresis on a 6 % polyacrylamide gel (Sambrook & Russell, 2001a) .
Results

Co-localization of HHV-6 IE1 with PML-bodies
Although two potential in-frame ATG initiation codon sites, 162 bp apart, have been identified in the HHV-6 strain U1102 IE1 sequence, only the upstream site is maintained in both A (U1102) and B (HST and Z29) variant IE1 gene sequences (Schiewe et al., 1994 ; Gompels et al., 1995 ; Isegawa et al., 1999 ; Dominguez et al., 1999) ; the upstream start site was therefore selected for expression of the strain U1102 IE1 gene. HHV-6 IE1 gene fusions were inserted into mammalian expression vectors both in native form and as GFP-fusion constructs as detailed in the Methods. Splicing of both HHV-6 IE1 variant mRNAs in transient transfections was found to match that previously published (data not shown) (Kondo et al., 2002 ; Schiewe et al., 1994) .
To examine the intracellular distribution of the HHV-6 IE1 gene product in eukaryotic cells, U373 cells were transfected with plasmids expressing GFP-tagged IE1 proteins from both A and B type HHV-6 variants. Proteins from both variant A (IE1 *%"aa -GFP) and B (IE1 "!()aa -GFP) were demonstrated during real-time imaging to traffic to and remain associated with punctate nuclear domains (data not shown). This observation was followed up with immunofluorescence experiments in which the endogenous fluorescence associated with expressed IE1
*%"aa -GFP and IE1 "!()aa -GFP was shown to colocalize with PML (Fig. 1) . When expressed in isolation, both IE1 *%"aa -GFP and IE1 "!()aa -GFP clearly traffic to and form a stable interaction with the PML-associated nuclear domain. Unlike its positional analogue in HCMV, the HHV-6 IE1 gene product did not obviously perturb the intracellular distribution of PML nor associate with chromatin in cells undergoing mitosis.
Association of HHV-6 IE-1 with SUMO-1
Both of the HCMV major IE proteins (IE1 %*"aa and IE2 &(*aa ) have been reported to form a covalent linkage with the small ubiquitin-like protein SUMO-1, an interaction that may play a crucial role in regulating their function (Hofmann et al., 2000 ; Xu et al., 2001) . Consequently, we wished to explore any potential relationship between the HHV-6 IE1 gene products and SUMO-1. In normal cells, SUMO-1 exhibits a diffuse nuclear distribution combined with a concentration at PMLbodies. To facilitate studies, a U373 cell line expressing a myc\ his-tagged version of SUMO-1 was generated (U373-SUMO). The U373-SUMO cell line was transfected with the pZ29-GFP and pU1102-GFP constructs and both IE1
*%"aa -GFP and IE1
"!()aa -GFP were observed to co-localize with SUMO-1 (Fig. 2) . Remarkably, levels of IE1 *%"aa -GFP and IE1 "!()aa -GFP fluorescence were also substantially enhanced in the U373-SUMO cell line. This observation was supported by data from Western blots (Fig. 3) in which IE1 "!()aa -GFP levels were substantially greater in the U373-SUMO cell line compared to control U373 cells. Similar results were obtained with the HHV-6 IE1 *%"aa -GFP construct. Levels of the HHV-6 IE1 protein accumulate over time, suggesting that its association with SUMO-1 may be enhancing its stability. Control U373 and U373-SUMO cells transfected with plasmids either expressing GFP alone or expressing a nuclear form of GFP [which has the nuclear localization signal (NLS) from exon 2 of CMV IE1] demonstrated approximately equal levels of GFP-expression in both cell types (Fig. 3) . Thus the difference in levels of HHV-6 IE1-GFP protein in the two cell types does not appear to be due to the ability of the cells to be transfected, or to differences in levels of expression of transfected DNA. In addition, no association of NLS-tagged GFP with PML was seen by immunofluorescence (data not shown), excluding the possibility that IE1
*%"aa -GFP or IE1 "!()aa -GFP traffic to PML bodies purely as a result of their overexpression.
The intranuclear distribution of IE1 "!()aa -GFP is altered in a subpopulation of transfected U373-SUMO cells, possibly as a consequence of its overexpression. In approximately 10 % of cells transfected with pZ29-GFP large intranuclear inclusions (one or two per cell) formed as both SUMO-1 and IE1 "!()aa -GFP accumulated (Fig. 2e-h ). While PML also associates with intranuclear inclusions induced in IE1 "!()aa -transfected U373-SUMO cells, some PML remains in small punctate domains (Fig. 2a-d) . The large intranuclear inclusion associated with SUMO-1 could not be detected in cells that did not exhibit IE1 "!()aa expression. Intranuclear inclusions were also not detected in cells transfected with the pU1102-GFP construct.
U373-SUMO cells expressing IE1
*%"aa -GFP exhibited only punctate staining while still co-localizing with PML and SUMO-1 (Fig. 2i-p) . SUMO-1 is clearly more strongly associated with a punctate nuclear structure in cells expressing either IE1
*%"aa -GFP or IE1 "!()aa -GFP (Fig. 2n, o, arrowed) .
HHV-6 IE1 is SUMO-1-modified
To detect expression of the HHV-6 IE1 gene product, an antibody specific for GFP was used in Western blot experiments. Two discrete protein species with estimated molecular CIBD R. Stanton and others R. Stanton and others Fig. 1. IE1 1078aa -GFP (a-d) or IE1 941aa -GFP (e-h) co-localizes with PML when transfected into U373 cells. Where indicated, cells were imaged by EGFP autofluorescence (b, f), DAPI (a, e) or by using a PML-specific monoclonal antibody (c, g). Fig. 2 . IE1 1078aa -GFP (a-h) or IE1 941aa -GFP (i-p) co-localizes with both PML and SUMO-1 in a U373 cell line overexpressing SUMO-1. Where indicated, cells were imaged by EGFP autofluorescence (b, f, j, n), DAPI (a, e, i, m) or by monoclonal antibodies specific for SUMO-1 (g, o) or PML (c, k). IE1 1078aa -GFP forms large nuclear inclusion bodies in approximately 10 % of transfected cells (b, f), as opposed to the normal punctate pattern of staining (see arrowed cell in f). The inclusion bodies remain co-localized with SUMO-1 (e-h). No such inclusion bodies are seen with IE1 941aa -GFP, which remains in a nuclear punctate pattern in all cells ( j, n). Cells expressing HHV-6 IE1 exhibit more punctate SUMO-1 staining than those not expressing HHV-6IE1 (compare arrowed cells in n and o with cells in the same field which are not expressing IE1 941aa -GFP).
Analysis of HHV-6 IE1 protein Analysis of HHV-6 IE1 protein Fig. 3 . HHV-6 IE1 is more stable in U373 cells overexpressing SUMO-1 (U373-SUMO) than in the parent cell line (U373). Control transfections with nuclear GFP (lanes 1-2) and GFP expressing plasmids (3-4) demonstrate equal levels of expression in both U373 and U373-SUMO cells at 48 h. IE1-GFP expression (5-8), demonstrating enhanced expression in U373-SUMO cell line compared to U373 cells at 48 h. All samples stained with anti-GFP monoclonal antibody. masses of approximately 235 and 260 kDa were detected in cells transfected with pZ29-GFP (Fig. 3.) . These values are significantly larger than the 147n5 kDa predicted size of the fusion protein (IE1 "!()aa is estimated at 121n5 kDa and GFP at 27 kDa). Interestingly, the HCMV major IE protein also migrates anomalously on SDS-PAGE suggesting a significantly higher apparent molecular mass than that predicted from its sequence. The presence of a second higher molecular mass species detected in Western blot experiments would be consistent with HHV-6 IE1 being covalently conjugated to SUMO-1.
To further investigate expression of HHV-6 IE1, the gene derived from strain U1102 was inserted into a replicationdeficient adenovirus vector. Mice were immunized with the adenovirus recombinant (RAdHHV-6) to generate limited CIBF R. Stanton and others R. Stanton and others amounts of HHV-6 IE1-specific polyclonal antibodies. Coimmunofluorescence using the murine antibody demonstrated that the native form of the HHV-6 IE *%"aa co-localized with PML-bodies when expressed following infection with RAdHHV-6 IE" (Fig. 4a) . No cross-reactivity of either secondary antibody with the incorrect primary antibody was seen, nor was any staining observed on the green channel when the same immunofluorescence was carried out on cells infected with empty adenovirus vector (data not shown). Cell extracts prepared from U373 cells infected with RAdHHV-6 IE" were analysed by Western blot using the HHV-6 IE1-specific polyclonal antibody. A major protein species with an estimated molecular mass of around 160 kDa was identified (by SDS-PAGE) (Fig. 4b) ; thus the native protein also migrates with an anomalous mobility. Although only a single predominant species was clearly identifiable for the native form of the protein, this does not exclude SUMO-modification since the gross overexpression of the protein from the adenovirus recombinant has the potential to overwhelm sumoylation pathways and mask detection of low abundance SUMOmodified species on Western blots.
Continuous cell lines stably expressing IE1 *%"aa -GFP and IE1 "!()aa -GFP were generated and an anti-GFP rabbit polyclonal antiserum was used to purify the GFP-fusion protein by immunoprecipitation. When analysed by Western blot, the fastest migrating IE1 *%"aa -GFP and IE1 "!()aa -GFP species reacted only with the GFP-specific antibody (Fig. 5) . These same bands also reacted with the HHV-6 IE1-specific antibody (data not shown). Two co-migrating species reacted with the SUMO-1-specific monoclonal antibody. The sizes of these additional protein species would be consistent with IE1 *%"aa -GFP and IE1 "!()aa -GFP being covalently conjugated with one CIBG Fig. 7 . HHV-6 does not disrupt PODs even at late times of the infectious life-cycle. Z29-infected Molt 3 cells (a-d), U1102-infected JJhan cells (e-h) and U1102-infected PBMC (i-l) co-stained for PML and HHV-6 late antigen.
and two SUMO-1 molecules (arrowed). A third slowermigrating species is strongly labelled with the SUMO-1-specific antibody but only weakly with the anti-GFP antibody. It was therefore concluded that the HHV-6 U1102-and Z29-variant IE1 proteins are subjected to covalent linkage with SUMO-1.
The fate of PML-bodies during productive HHV-6 infection
In transient DNA transfection, HHV-6 IE1 migrates to PML-bodies without exerting any obvious effect on their integrity. We wished to investigate the fate of both the HHV-6 IE gene product and PML-bodies during productive HHV-6 infection. HHV-6 exhibits restricted tropism and growth properties in vitro. To analyse HHV-6 during the lytic cycle, co-immunofluorescence assays were performed on cells infected with both HHV-6A U1102 (grown in PBMC and JJhan cells) and HHV-6B Z29 (grown in Molt 3 cells) using the murine polyclonal anti-IE1 antibody and the rabbit anti-PML antibody. Both HHV-6 U1102 and Z29 IE1 gene products exhibited a punctate nuclear distribution and co-localized with PML-bodies (Fig. 6) . In both HHV-6 variants, on average three nuclear domains per cell were immunolabelled, although the actual number per cell ranged from two to five. The disruption of PML-bodies is a common feature of herpesvirus infection ; thus their persistence during lytic infection was unexpected. To address this issue directly, a further coimmunofluorescence experiment was undertaken with an antibody known to be specific for a late HHV-6 antigen (Fox et al., 1990) . Even in cells expressing HHV-6 late antigen, we were unable to detect any obvious effect on the integrity of PML-bodies for HHV-6A in PBMC or HHV-6A and HHV-6B in continuous T cell lines (Fig. 7) . Thus productive HHV-6 infection does not promote the destruction of PML-associated nuclear domains.
Discussion
The HHV-6 IE1 gene product was demonstrated to be a nuclear protein that associates with PML-bodies without compromising their integrity and to be post-translationally modified by conjugation to SUMO-1. The IE1 genes of HHV-6A strain U1102 and HHV-6B strain Z29 exhibit a substantially higher level of sequence divergence than other HHV-6 genes and therefore both genes were studied in parallel. Both HHV-6 IE1 proteins were observed to migrate anomalously when analysed by SDS-PAGE, indicating significantly higher molecular masses than predicted from their sequence. The strain U1102 IE1 gene product is predicted to encode a 104 kDa product but the protein expressed using an adenovirus vector migrates with an apparent size of 160 kDa. The HCMV IE1 gene product also migrates anomalously, a property associated with the presence of a large C-terminal acidic domain (Wilkinson et al., 1998) . Although the strain Z29 IE1 "!()aa protein exhibited a tendency to form large intracellular aggregates when expressed in the U373-SUMO cell line, no clear biological differences were observed in assays performed with the two constructs.
PML-bodies have been implicated in a wide range of cellular processes including transcriptional control, chromatin CIBH R. Stanton and others R. Stanton and others remodelling, apoptosis, cellular transformation and immune regulation. PML expression is stimulated by treatment with interferon and its enhanced association with its nuclear domain may act as a barrier to virus infection (Bonilla et al., 2002) . Following infection, the HCMV genome traffics to PMLbodies and this is the site at which virus transcription and DNA replication are established Maul et al., 1996 ; Ahn et al., 1999) . Expression of the HCMV IE1 gene product promotes the disruption of PML-bodies, causing the PML protein to be dispersed throughout the nucleus and to associate with mitotic chromatin. It is not clear why DNA virus genomes are deposited at PML-bodies nor why viruses encode genes that compromise their integrity. Herpes simplex virus 1 ICP0 promotes both the dissolution of PML-bodies and the degradation of PML, Epstein-Barr virus BZLF1 promotes the nuclear dispersal of PML without its degradation and the adenovirus E4 ORF3 induces the formation of thread-like PML-structures (Adamson & Kenney, 2001 ; Everett & Maul, 1994 ; Carvalho et al., 1995) . HHV-6 IE1 is clearly functionally distinct from its positional analogue in HCMV in leaving PMLbodies superficially intact. Additionally, PML-bodies remain superficially intact in JJhan or Molt 3 lymphocytic cell lines and in PBMC cultures infected with either the HHV-6A or HHV-6B variant. HHV-6 infection is remarkable for not promoting the disruption or destruction of these nuclear domains.
In addition to PML, a large number of cellular proteins have been reported to either transiently or stably associate with PML-bodies, including p53, Rb, CBP, Daxx, Bax and SP100 (Zhong et al., 2000) . Furthermore, a significant number of viral proteins traffic to PML-bodies without perturbing their integrity, e.g. HCMV IE2, EBV EBNA-5, HHV-8 K8, simian virus 40 T Ag, bovine papillomavirus E2, L1 and L2 (Ahn & Hayward, 1997 ; Katano et al., 2001 ; Murges et al., 2001 ; Szekely et al., 1996 ; Day et al., 1998 ; Jiang et al., 1996 ; Bonilla et al., 2002) . Currently, the HHV-6 IE gene product has not been assigned any specific function. However, the strong association revealed by immunohistochemistry and real-time imaging suggests that HHV-6 IE1 may act by affecting the function of PML-bodies. HHV-6 IE1 clearly has the potential to modify components, regulate the composition, or influence trafficking to and from PML-bodies without inducing a morphological change.
SUMO-1 is conjugated to proteins by a thioester bond formed between the C terminus of SUMO-1 and a lysine residue in the targeted protein. Unlike ubiqitination, which targets proteins for degradation, modification by SUMO-1 can have a variety of different effects. Most significantly, SUMO-1 modification of the PML protein is necessary for its localization to PML-bodies and the trans-activating function of HCMV IE2 (Hofmann et al., 2000 ; Rodriguez et al., 1999) . We observed that expression of the HHV-6 IE1-GFP fusion protein, but not GFP alone, was substantially enhanced in a U373-SUMO-1 cell line. It is therefore likely that sumoylation is required to stabilize the expressed HHV-6 IE1 gene product. This situation would not be unique ; SUMO-1-modified IκBα and Mdm2 are resistant to ubiquitin-mediated degradation (Desterro et al., 1998) . Herpesvirus IE proteins are associated with establishment of a cellular environment compatible with the lytic phase of infection. SUMO-1 modification can be induced in response to stress. The heat-shock transcription factors 1 and 2 (HSF1 and HSF2) are both converted to their DNA-binding form by SUMO-1 modification in response to stress (Hong et al., 2001) , while DNA damage induces SUMOmodification of topoisomerase I and II (Goodson et al., 2001 ; Mao et al., 2000) . It is possible that in both HCMV and HHV-6 infections the transition from latent to the lytic replication cycle may be promoted by the SUMO-1 modification of IE gene products. Sumoylation pathways may play an important role in determining the fate of betaherpesvirus infections.
On analysing the level of sumoylation of the HHV-6 IE protein three slower-migrating species were identified that would be consistent with the protein containing three sumoylation sites. This degree of sumoylation would be unusual, although PML has been demonstrated to have three SUMO-modification sites. However, analysis of the IE1 gene sequence revealed only a single consensus sequence for SUMO-1 modification (I\LKXE) in both U1102 and Z29 IE1 sequences at amino acids 665 and 802 respectively. Further cryptic sites may yet be present. Alternatively, conjugation with a single SUMO-1 molecule could potentially facilitate a second SUMO-1-independent modification resulting in reduced mobility, e.g. ubiquitination. Further analysis of the protein is required to determine the number of SUMO-1-modification sites it contains.
Note added in proof. Since submission of this article, the following related paper has been published which describes the behaviour of the HHV-6 variant B IE1 protein in transient transfection and lytic virus infection : Gravel et al., Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukaemia protein-associated nuclear bodies. Journal of Biological Chemistry 277, 19679-19687, 2002. 
